Evidence map›Paper›PMID 33117451›Full record

ArticleEuropean endocrinology2020

Insulin Autoimmune Syndrome - A Case Series.

Hiya Boro, Uttio Gupta, Charandeep Singh, Rakhi Malhotra, Rajesh Khadgawat

Abstract readCase Reports
In one paragraph

Article in European endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Hirata Syndrome Clinical Presentation and Management: A Single-Centre Experience.Journal of the ASEAN Federation of Endocrine Societies · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  9. Insulin Autoimmune Syndrome: A Systematic Review.International journal of endocrinology · 2023
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiya BoroDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Uttio GuptaDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Charandeep SinghDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Rakhi MalhotraDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Rajesh KhadgawatDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin autoimmune syndrome, or Hirata's disease, is a rare cause of hypoglycaemia. It is characterised by spontaneous episodes of hypoglycaemia, without any exposure to exogenous insulin. The majority of cases are seen in the Japanese population and it is rarely found to affect other ethnicities. The recognition of this disease is important to avoid unnecessary investigations and procedures. Here, we report two cases of insulin autoimmune syndrome, which were diagnosed and managed in our institute.

Indexed as

Hirata’s diseaseinsulin autoantibodiesInsulin autoimmune syndromeinsulin to C-peptide ratiopost-absorptive hypoglycaemia

Identifiers

PMID33117451
PMCPMC7572167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.